Molecular-Clinical Profiles in Fragile X: Novel FMR1 Genetic and Epigenetic Molecular Assessments in a Cohort of Full-Mutation and Premutation Patients

Budimirovic, Dejan B.

Symposium Presentation 28.3
Molecular-Clinical Profiles in Fragile X: Novel FMR1 Genetic and Epigenetic Molecular Assessments in a Cohort of Full-Mutation and Premutation Patients

Friday, October 24, 2014 8:30 AM

Dejan B. Budimirovic, MD, Medical Director, Fragile X Clinic, KKI, JHMI, Clinical Trials Center, Kennedy Krieger Institute, The Johns Hopkins Medical Institutions, Baltimore, MD

See more of: Fragile X-Associated Disorders: Illuminating the Spectrum of Disease Through Molecular, Clinical, and Therapeutic Advances
See more of: Symposium

61st Annual Meeting

October 18 - 25, 2014

Program Navigation

Symposium Presentation 28.3
Molecular-Clinical Profiles in Fragile X: Novel FMR1 Genetic and Epigenetic Molecular Assessments in a Cohort of Full-Mutation and Premutation Patients

Symposium Presentation 28.3 Molecular-Clinical Profiles in Fragile X: Novel FMR1 Genetic and Epigenetic Molecular Assessments in a Cohort of Full-Mutation and Premutation Patients

Symposium Presentation 28.3
Molecular-Clinical Profiles in Fragile X: Novel FMR1 Genetic and Epigenetic Molecular Assessments in a Cohort of Full-Mutation and Premutation Patients